Industry sustainability case studies
The examples in this study provide a snapshot of the activities happening around the world to cut carbon emissions, save water, cut waste, sustainably design products.
Read more
November 5, 2021 –We, as founding members of AMATA, representing patients, academia, civil society, and industry, welcome the official ratification of the AMA Treaty, which has enabled the African Medicines Agency to effectively enter into force today. We now call on the African Union to build on the current momentum gained with the legal deposition...
Read moreGlobal public health is inextricably linked to the health of the planet. Climate change, air pollution and other environmental challenges have a demonstrable impact on public health around the world.
Read moreThe examples in this study provide a snapshot of the activities happening around the world to cut carbon emissions, save water, cut waste, sustainably design products.
Read more
On 7 July 2021, the biopharmaceutical industry welcomed the opportunity to join the International Coalition of Medicines Regulatory Authorities (ICMRA) in a workshop focused on expanding manufacturing capacity for COVID-19 medicines and vaccines. This workshop provided a platform to collectively explore the range of activities associated with post-approval site transfers and review the regulatory flexibilities...
Read moreThe annual World Health Summit (WHS) provided a platform for the global health community to take stock of the world’s response to the current COVID-19 pandemic, as well other pressing health threats, such as the rise of antimicrobial resistance, which could next sweep the world. At the WHS, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) announced its policy perspectives on preparing society against future pandemics.
Read moreThis month, COVID-19 vaccine manufacturing output will pass the 9.3 billion dose mark. The biopharmaceutical industry renews its May commitment to the G20 to collaborate with governments to support effective solutions to urgently address vaccine equity. At current production rates, swiftly rolling out vaccines to those who still need them looks achievable, if the political...
Read moreThe session featured government and private sector leaders to officially launch the modernized APEC Kuala Lumpur and Mexico City Principles to commence the implementation process. This session also debuted a novel piece of research to serve all stakeholders in the initiative to create a better understanding of the impact of ethical business practices, especially amidst COVID-19.
Read more
This position paper details two ambitious objectives of the pharmaceutical industry: Aim to develop effective and safe pandemic products within 100 days of a new pandemic declaration. To Collaborate with governments, multilateral organizations, regulators, and other companies and sectors to ensure equitable access to those products for people worldwide.
Read more
Certification Scheme for a Certificate of Pharmaceutical Product (CPP) - IFPMA CPP Network Training Toolkit
Read more
Last flu season was exceptionally mild because of the measures used to contain COVID-19, like physical distancing and masks. But what will the upcoming flu season look like?
Read moreThe #TogetherAgainstFlu online campaign aims to keep raising awareness of the importance of flu vaccinations for healthcare workers, older adults and patients living with chronic conditions.
Read more
The Certificate of Pharmaceutical Product (CPP) is a document issued by a country’s regulatory authority at the request of a product owner to support the registration process of a pharmaceutical product of another regulatory authority in a different country. IFPMA's work on CPP focuses on the benefits of this tool as a reliance tool.
Read more